1 idea from this batch

Eli Lilly's new weight-loss drug wows Wall Street — ride the breakout higher

Eli Lilly is already a dominant player in the obesity drug market, but these strong trial results confirm their pipeline has staying power against competitors. Analysts at major banks have pointed out that the company's portfolio is well-di